Related Experiment Video
Updated: Jul 2, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[Renal function in white rats after tiroxin injection preceded by blockade of ACE and nitrogen oxide]
Abstract:
Purpose of this work was to study renal function in white rats following a single dose of exogenous tiroxin (T4) on a background of non-selective NO-synthase blocker or inhibition of angiotensin-1 converting enzyme. The experiment was performed with males of outbred white rats (body mass = 140-180 g). Three days prior to T4 injection, the animals drank water solution of captopril (20 mg/l) or were injected intra-gastrically with water solution of non-selective NO-synthase blocker N(omega)-NLA (1 mg/100 g of body mass) over 3 days preceding T4 injection. A single dose of sodium chloride T4 on 1% starch gel (50 microg/100 g of body mass) was injected intragastrically; 5% water loading was given one hour later. Urine and plasma samples were analyzed for osmolality; creatinine, nitrites, nitrates and proteins were measured in urine samples. Tirozine was found to moderately decrease creatinine clearance and increase excretion of proteins, osmotically active substances (OAS), nitrites and nitrates with urine, and raise concentrations of stable nitrogen oxides, primarily nitrates in blood plasma. Pre-block of ACE by captopril intensified diuresis and inhibited renal excretion of OAS, nitrites and nitrates in response to T4 injection. However, captopril failed to prevent the decrease in creatinine clearance and the level of proteinuria. Pre-block of NO synthesis resulted in marked decreases in creatinine clearance, excretion of OAS and nitrites, and moderation of diuresis comparing with intact rats and rats treated with T4 only.
Insights
Thyroxine (T4) impacts kidney function, decreasing creatinine clearance and increasing protein excretion. Blocking nitric oxide (NO) synthesis or angiotensin-converting enzyme (ACE) with captopril alters these effects, highlighting complex renal responses.
Area of Science:
- Nephrology
- Endocrinology
- Pharmacology
Background:
- Thyroxine (T4) administration can influence renal function.
- Nitric oxide (NO) and the renin-angiotensin-aldosterone system (RAAS) play critical roles in regulating kidney physiology.
- Understanding the interplay between T4, NO, and ACE is crucial for managing renal health.
Purpose of the Study:
- To investigate the effects of exogenous thyroxine (T4) on renal function in rats.
- To examine how non-selective NO-synthase blockade or angiotensin-converting enzyme (ACE) inhibition modifies T4-induced renal changes.
- To elucidate the specific roles of NO and ACE pathways in mediating T4's impact on the kidneys.
Main Methods:
- Male Wistar rats were administered T4 intragastrically.
- Animals were pre-treated with captopril (ACE inhibitor) or N(omega)-NLA (NO-synthase blocker).
- Renal function was assessed by measuring urine and plasma osmolality, creatinine clearance, proteinuria, and nitrogen oxide levels.
Main Results:
- T4 administration moderately decreased creatinine clearance and increased proteinuria, urinary osmolality, and excretion of nitrites and nitrates.
- Captopril pre-treatment intensified diuresis but reduced the excretion of osmotically active substances (OAS) and nitrites in response to T4, without preventing reduced creatinine clearance or proteinuria.
- NO synthesis pre-block significantly decreased creatinine clearance, OAS excretion, and nitrites, while moderating diuresis compared to T4-only treated rats.
Conclusions:
- Exogenous thyroxine significantly alters renal function, impacting creatinine clearance, proteinuria, and nitrogen oxide metabolism.
- The ACE pathway, while influencing diuresis and excretion, does not fully prevent T4-induced renal dysfunction.
- NO synthesis inhibition markedly exacerbates T4-induced reductions in renal function, underscoring the protective role of NO in this context.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Acute Kidney Injury II: Pathophysiology
